BBY
Best Buy Co., Inc.
BBY has the edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BBY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
BBY's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BBY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $66.80 | -35% |
| Fair | 14x | $83.80 | -19% |
| Forward | 15x | $103 | — |
| Expensive | 17x | $104 | +0.3% |
| Current | 17x | $103 | — |
Historical ranges are pointers, not guarantees.
BBY's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its fair range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BBY Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Moderate | |
| High |
Analysts expect BBY's earnings to grow, with its revenue and profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BBY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.12 | +18% |
| Q3 2026 | $6.01 | +66% |
| Q2 2026 | $5.40 | +32% |
| Q1 2026 | $5.04 | +18% |
| Q4 2025 | $3.03 | -48% |
| Q3 2025 | $3.63 | -37% |
| Q2 2025 | $4.10 | -28% |
| Q1 2025 | $4.28 | -25% |
| Q4 2024 | $5.84 | +0.7% |
BBY has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BBY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.8B | +3.6% |
| Q2 2026 | $8.9B | +1.9% |
| Q1 2026 | $13.8B | -1% |
| Q4 2025 | $9.7B | +2.4% |
| Q3 2025 | $9.4B | +1.6% |
| Q2 2025 | $8.8B | -0.9% |
| Q1 2025 | $13.9B | -4.8% |
| Q4 2024 | $9.4B | -3.2% |
BBY's revenue fell from its 2021 peak and has held roughly level since: $9.8B last quarter, up 3.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +1.6 points |
| Q2 2026 | 4.1% | +1.6 points |
| Q1 2026 | 5.2% | +3.7 points |
| Q4 2025 | 2% | -1.7 points |
| Q3 2025 | 2.7% | -1.5 points |
| Q2 2025 | 2.5% | -1 points |
| Q1 2025 | 1.6% | -2.3 points |
| Q4 2024 | 3.7% | +0.1 points |
BBY has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BBY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BBY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $737M | +28% |
| Q2 2026 | $215M | +$347M |
| Q1 2026 | $1.1B | -19% |
| Q4 2025 | -$287M | +$162M |
| Q3 2025 | $574M | +20% |
| Q2 2025 | -$132M | -3400% |
| Q1 2025 | $1.4B | +36% |
| Q4 2024 | -$449M | -$341M |
BBY has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BBY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | 0.0x | Very low |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | 0.2x | Very low |
BBY has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BBY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.5 | Overbought |
BBY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BBY PE vs Consumer Cyclical Sector
| Metric | BBY | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 4.5% below |
| PE % | 82 | 47 | 35 pts above |
BBY is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BBY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $94.6 | 9.3% above |
| 20 week MA | $89.3 | 16% above |
| 50 week MA | $76.1 | 36% above |
| 100 week MA | $75.6 | 37% above |
| 200 week MA | $77.9 | 33% above |
BBY has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BBY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $87.0 | $102.6 | +18% |
| 2021 | $102.6 | $98.1 | -4.4% |
| 2022 | $98.1 | $81.4 | -17% |
| 2023 | $81.4 | $78.3 | -3.8% |
| 2024 | $78.3 | $88.0 | +12% |
| 2025 | $88.0 | $69.6 | -21% |
| 2026 YTD | $69.6 | $103.4 | +49% |
BBY has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.